|
1
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut. 66:683–691. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu S, Zheng R, Zhang M, Zhang S, Sun X
and Chen W: Incidence and mortality of colorectal cancer in China,
2011. Chin J Cancer Res. 27:22–28. 2015.PubMed/NCBI
|
|
4
|
Marley AR and Nan H: Epidemiology of
colorectal cancer. Int J Mol Epidemiol Genet. 7:105–114.
2016.PubMed/NCBI
|
|
5
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Slaby O, Svoboda M, Michalek J and Vyzula
R: MicroRNAs in colorectal cancer: Translation of molecular biology
into clinical application. Mol Cancer. 8:1022009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun K, Wang W, Zeng JJ, Wu CT, Lei ST and
Li GX: MicroRNA-221 inhibits CDKN1C/p57 expression in human
colorectal carcinoma. Acta Pharmacol Sin. 32:375–384. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sassen S, Miska EA and Caldas C: MicroRNA:
Implications for cancer. Virchows Arch. 452:1–10. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Howe JR VIth, Li ES, Streeter SE, Rahme
GJ, Chipumuro E, Russo GB, Litzky JF, Hills LB, Rodgers KR, Skelton
PD and Luikart BW: MiR-338-3p regulates neuronal maturation and
suppresses glioblastoma proliferation. PLoS One. 12:e01776612017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang X, Wang C, Li H, Niu X, Liu X, Pei
D, Guo X, Xu X and Li Y: miR-338-3p inhibits the invasion of renal
cell carcinoma by downregulation of ALK5. Oncotarget.
8:64106–64113. 2017.PubMed/NCBI
|
|
11
|
Huang N, Wu Z, Lin L, Zhou M, Wang L, Ma
H, Xia J, Bin J, Liao Y and Liao W: MiR-338-3p inhibits
epithelial-mesenchymal transition in gastric cancer cells by
targeting ZEB2 and MACC1/Met/Akt signaling. Oncotarget.
6:15222–15234. 2015.PubMed/NCBI
|
|
12
|
Shang C, Hong Y, Guo Y and Xue YX:
Mir-338-3p inhibits malignant biological behaviors of glioma cells
by targeting MACC1 gene. Med Sci Monit. 22:710–716. 2016.PubMed/NCBI
|
|
13
|
Tsuchiya S, Oku M, Imanaka Y, Kunimoto R,
Okuno Y, Terasawa K, Sato F, Tsujimoto G and Shimizu K:
MicroRNA-338-3p and microRNA-451 contribute to the formation of
basolateral polarity in epithelial cells. Nucleic Acids Res.
37:3821–3827. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang G and Sun Y, He Y, Ji C, Hu B and Sun
Y: MicroRNA-338-3p inhibits cell proliferation in hepatocellular
carcinoma by target forkhead box P4 (FOXP4). Int J Clin Exp Pathol.
8:337–344. 2015.PubMed/NCBI
|
|
15
|
Kelemen LE, Wang X, Fredericksen ZS,
Pankratz VS, Pharoah PD, Ahmed S, Dunning AM, Easton DF, Vierkant
RA, Cerhan JR, et al: Genetic variation in the chromosome 17q23
amplicon and breast cancer risk. Cancer Epidemiol Biomarkers Prev.
18:1864–1868. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hirata Y, Murai N, Yanaihara N, Saito M,
Saito M, Urashima M, Murakami Y, Matsufuji S and Okamoto A:
MicroRNA-21 is a candidate driver gene for 17q23-25 amplification
in ovarian clear cell carcinoma. BMC Cancer. 14:7992014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guo B, Liu L, Yao J, Ma R, Chang D, Li Z,
Song T and Huang C: miR-338-3p suppresses gastric cancer
progression through a PTEN-AKT axis by targeting P-REX2a. Mol
Cancer Res. 12:313–321. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wen C, Liu X, Ma H, Zhang W and Li H:
miR-338-3p suppresses tumor growth of ovarian epithelial carcinoma
by targeting Runx2. Int J Oncol. 46:2277–2285. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Stein U, Walther W, Arlt F, Schwabe H,
Smith J, Fichtner I, Birchmeier W and Schlag PM: MACC1, a newly
identified key regulator of HGF-MET signaling, predicts colon
cancer metastasis. Nat Med. 15:59–67. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dunlevy JR, Berryhill BL, Vergnes JP,
SundarRaj N and Hassell JR: Cloning, chromosomal localization, and
characterization of cDNA from a novel gene, SH3BP4, expressed by
human corneal fibroblasts. Genomics. 62:519–524. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hua FF, Liu SS, Zhu LH, Wang YH, Liang X,
Ma N and Shi HR: MiRNA-338-3p regulates cervical cancer cells
proliferation by targeting MACC1 through MAPK signaling pathway.
Eur Rev Med Pharmacol Sci. 21:5342–5352. 2017.PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang J, Chen JX, Chen L, Tang JY, Cui Z,
Liu CH and Wang Z: Metastasis associated in colon cancer 1 (MACC1)
promotes growth and metastasis processes of colon cancer cells. Eur
Rev Med Pharmacol Sci. 20:2825–2834. 2016.PubMed/NCBI
|
|
24
|
Sun K, Su G, Deng H, Dong J, Lei S and Li
G: Relationship between miRNA-338-3p expression and progression and
prognosis of human colorectal carcinoma. Chin Med J (Engl).
127:1884–1890. 2014.PubMed/NCBI
|
|
25
|
Cohen-Solal KA, Boregowda RK and Lasfar A:
RUNX2 and the PI3K/AKT axis reciprocal activation as a driving
force for tumor progression. Mol Cancer. 14:1372015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Walker CL, Liu NK and Xu XM: PTEN/PI3K and
MAPK signaling in protection and pathology following CNS injuries.
Front Biol (Beijing). 8:2013.doi: 10.1007/s11515-013-1255-1.
PubMed/NCBI
|
|
27
|
Wang G, Fu Z and Li D: MACC1
overexpression and survival in solid tumors: A meta-analysis.
Tumour Biol. 36:1055–1065. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li H, Chen YX, Wen JG and Zhou HH:
Metastasis-associated in colon cancer 1: A promising biomarker for
the metastasis and prognosis of colorectal cancer. Oncol Lett.
14:3899–3908. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ashktorab H, Hermann P, Nouraie M,
Shokrani B, Lee E, Haidary T, Brim H and Stein U: Increased MACC1
levels in tissues and blood identify colon adenoma patients at high
risk. J Transl Med. 14:2152016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Birchmeier C, Birchmeier W, Gherardi E and
Vande Woude GF: Met, metastasis, motility and more. Nat Rev Mol
Cell Biol. 4:915–925. 2003. View
Article : Google Scholar : PubMed/NCBI
|
